Quizartinib, the next FLT3 inhibitor

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	240-243
Number of pages	4
Journal	Clinical advances in hematology & oncology : H&O
Volume	21
Issue number	5
State	Published - May 1 2023

ASJC Scopus subject areas

@article{9ab324c823f641a987a0679004388d3a,

title = "Quizartinib, the next FLT3 inhibitor",

author = "Jorge Cortes",

year = "2023",

month = may,

day = "1",

language = "English (US)",

volume = "21",

pages = "240--243",

journal = "Clinical advances in hematology & oncology : H&O",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "5",

}

TY - JOUR

T1 - Quizartinib, the next FLT3 inhibitor

AU - Cortes, Jorge

PY - 2023/5/1

Y1 - 2023/5/1

UR - http://www.scopus.com/inward/record.url?scp=85159553315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159553315&partnerID=8YFLogxK

M3 - Article

C2 - 37145493

AN - SCOPUS:85159553315

SN - 1543-0790

VL - 21

SP - 240

EP - 243

JO - Clinical advances in hematology & oncology : H&O

JF - Clinical advances in hematology & oncology : H&O

IS - 5

ER -